Page 83 - IJB-9-3
P. 83

International Journal of Bioprinting                        3DP hydrogels to combat antibiotic-resistant bacteria



            Table 3. Results of Rif MIC and rpoB genotyping
             Strain                        Rif MIC (μg/mL)  Amino acid position  Nucleotide substitution  Amino acid substitution
             S. aureus RN4220              0.0019       No change       No change          No change
             S. aureus Rif R               ≥ 128        463             AGC→AGA            S463R
                                                        471             GAC→GGC            D471G
                                                        484             CGT→CAT            R484H
             S. aureus RN4220 after contact with GelMA-  0.0019  No change  No change      No change
             C-NPs
             S. aureus RN4220 after contact with GelMA-  ≥ 128  463     AGC→AGA            S463R
             Rif-NPs                                    471             GAC→GGC            D471G
                                                        484             CGT→CAT            R484H
             S. aureus AMC 201             8            No change       No change          No change
             S. aureus AMC 201 after contact with    ≥ 128  No change   No change          No change
             GelMA-Rif-NPs
             S. aureus AMC 201 after contact with   8   No change       No change          No change
              GelMA-C-NPs
            Changes compared to rpoB sequence of the NCBI Reference Sequence of S. aureus RN4220 (NZ_CP076105.1) are indicated.
            hyaluronic acid hydrogel that prevented infection in a   3D-printed antibiotic-loaded hydrogels can be
            bone fracture-related infection rabbit model , or the   designed and  applied for  tissue  engineering applications
                                                  [45]
            coating of a prosthesis with tobramycin- and Van-loaded   or coatings of medical implants for the prevention or
            HA-PLA-PEG hydrogels . In view of the fast diffusion of   treatment of bacterial infections. Combining antibiotics
                                [46]
            compounds from hydrogels, providing a sustained release   for prevention or treatment of antimicrobial infections
            of antibiotics from hydrogels could be challenging.   may be chosen for incorporation into the hydrogels to be
            Therefore, in this work, we incorporated Rif-NPs and   printed before implantation. In this study, we designed
            Van-NPs within a hydrogel to obtain a sustained drug   and developed 3D-printed gelatin-methacrylate (GelMA)
            release.                                           hydrogels carrying PLGA NPs loaded with Van, Rif, or a
               Moreover, some antibiotics are not soluble in water,   combination of both. This technology enables the design
            so new approaches are needed to incorporate such   and manufacturing of a personalized antimicrobial
            hydrophobic drugs in the hydrogels. In this work, we   application with a gradual and controlled antibiotic
            included Van (hydrophilic) and Rif (hydrophobic)   release  system  to  prevent  or  treat  bacterial  infections.
            in PLGA NPs using two different techniques: (i) the   The antimicrobial activity was evaluated  in vitro against
            single (for hydrophobic drugs) and (ii) the double (for   S. aureus strain  RN4220 and RN4220  Rif- and  RN4220
            hydrophilic drugs) emulsion and evaporation process. The   Van-resistant isolates of this strain and against the clinical
            drug release from PLGA NPs using different molecular   S. aureus strain AMC 201. The results showed the complete
            weights was studied. A correlation between the molecular   eradication of bacteria by the 3D-printed hydrogel with
            weight and the release rate was observed for Rif-NPs and   the dual antibiotic-release NPs. The combination of two
            Van-NPs, showing that the low molecular weight had the   antibiotics, such as Rif and Van, in PLGA NPs loaded in
            highest release rate after 7 days. These results are aligned   the GelMA hydrogel provided sufficient protection against
            with previous studies. Makino et al. showed that the release   different S. aureus strains, including the single antibiotic-
            rate of Rif from PLGA microparticles was highly correlated   resistant S. aureus strains. Importantly, contact of S. aureus
            to the molecular weight . Ozalp et al. obtained similar   RN4220 with the GelMA-Rif-NPs alone induced the
                                [47]
            results in their study, where they analyzed the release of   development of resistance against Rif, showing the danger
                                                        [48]
            Van from PLGA NPs using different molecular weights .   of using Rif alone. Interestingly, although Rif resistance was
            They  observed  that  the  lowest  molecular  weight  PLGA   easily selected if the non-resistant S. aureus RN4220 were
            showed the highest release rate of Van. Regarding the   incubated with hydrogels releasing only Rif, the selection
            endcap group of PLGA, an acid endcap was reported to   of Rif resistance did not easily occur when  S. aureus
            show a significant faster release than an ester endcap, as the   RN4220 resistant to Van were used. The resistance to Van
            acid endcap group promotes the autocatalytic hydrolysis of   prevented S. aureus to easily develop resistance to Rif. This
            the polymer, and hence, a faster degradation and release of   is an important notion since it means that the combination
            the drug. All the PLGA polymers studied in this work were   with Van enables Rif to kill S. aureus even when these have
            acid endcap .                                      developed resistance to Van.
                     [49]

            Volume 9 Issue 3 (2023)                         75                         https://doi.org/10.18063/ijb.683
   78   79   80   81   82   83   84   85   86   87   88